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Exercise for depression in elderly residents of care homes: 
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Stephen A Bremner, Angela Devine, Karla Diaz-Ordaz, David R Ellard, Rachel Potter, Kathleen Spanjers, Stephanie J C Taylor
Summary
Background Depression is common and is associated with poor outcomes among elderly care-home residents. 
Exercise is a promising low-risk intervention for depression in this population. We tested the hypothesis that a 
moderate intensity exercise programme would reduce the burden of depressive symptoms in residents of care homes.
Methods We did a cluster-randomised controlled trial in care homes in two regions in England; northeast London, and 
Coventry and Warwickshire. Residents aged 65 years or older were eligible for inclusion. A statistician independent of the 
study randomised each home (1 to 1·5 ratio, stratiﬁ ed by location, minimised by type of home provider [local authority, 
voluntary, private and care home, private and nursing home] and size of home [<32 or ≥32 residents]) into intervention 
and control groups. The intervention package included depression awareness training for care-home staﬀ , 45 min 
physiotherapist-led group exercise sessions for residents (delivered twice weekly), and a whole home component designed 
to encourage more physical activity in daily life. The control consisted of only the depression awareness training. 
Researchers collecting follow-up data from individual participants and the participants themselves were inevitably aware 
of home randomisation because of the physiotherapists’ activities within the home. A researcher masked to study 
allocation coded NHS routine data. The primary outcome was number of depressive symptoms on the geriatric depression 
scale-15 (GDS-15). Follow-up was for 12 months. This trial is registered with ISRCTN Register, number ISRCTN43769277.
Findings Care homes were randomised between Dec 15, 2008, and April 9, 2010. At randomisation, 891 individuals in 
78 care homes (35 intervention, 43 control) had provided baseline data. We delivered 3191 group exercise sessions 
attended on average by ﬁ ve study participants and ﬁ ve non-study residents. Of residents with a GDS-15 score, 
374 of 765 (49%) were depressed at baseline; 484 of 765 (63%) provided 12 month follow-up scores. Overall the 
GDS-15 score was 0·13 (95% CI –0·33 to 0·60) points higher (worse) at 12 months for the intervention group 
compared with the control group. Among residents depressed at baseline, GDS-15 score was 0·22 (95% CI 
–0·52 to 0·95) points higher at 6 months in the intervention group than in the control group. In an end of study 
cross-sectional analysis, including 132 additional residents joining after randomisation, the odds of being depressed 
were 0·76 (95% CI 0·53 to 1·09) for the intervention group compared with the control group.
Interpretation This moderately intense exercise programme did not reduce depressive symptoms in residents of care 
homes. In this frail population, alternative strategies to manage psychological symptoms are required.
Funding National Institute for Health Research Health Technology Assessment.
Introduction
A growing number of elderly people (ie, older than 
65 years) live in residential accommo dation, which oﬀ ers 
assistance with personal, and in some cases nursing, 
care. Clinically signiﬁ cant depres sion is very common 
among residents of care homes1 and is associated with 
poor outcomes, including frailty and increased mortality.2 
Exercise is a promising, low-risk intervention that might 
be helpful in prevention and treatment of depression in 
this group.3–5 We describe a cluster randomised trial to 
test the hypothesis that a moderate intensity exercise 
programme would reduce the burden of depressive 
symptoms in residents of care homes.
Methods
Study design and participants
Full details of the trial methods and conduct are avail-
able elsewhere;6–8 they are brieﬂ y summarised here. We 
approached all care homes with between 16 and 70 beds 
in two locations in the UK; Coventry and Warwickshire, 
and northeast London. Care homes were excluded when 
fewer than six residents were likely to take part in the 
study, or when most residents either had severe cognitive 
impairment or were non-English speaking.
Once care homes had agreed to participate, we invited 
residents to give written, informed consent, or if they 
lacked capacity to consent, for their next of kin to give 
written, informed agreement for us to collect data directly 
from participants, from care-home staﬀ , and from care-
home and National Health Service (NHS) records. We 
included English speaking, per manent residents, aged 
65 years or older. We excluded residents who were too ill 
to approach at the time of recruitment visits or who had 
severe communication problems, those with a terminal 
illness, and those whom the care-home manager believed 
it was inappropriate to approach at the time of recruitment 
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(eg, when a resident had a recent bereavement). We 
provided participant information sheets in larger print 
and audio format for residents with poor eyesight. The 
recruitment team, who were all nurses or physiotherapists 
with experience of working with elderly people, received 
additional training from the study ethicist in the 
assessment of capacity to consent to this research. To help 
maximise completion of patient-reported outcomes these 
instruments were administered orally; the primary 
outcome was always completed ﬁ rst. When a resident 
was unable or unwilling to provide outcome data a further 
attempt was made to collect data on a subsequent visit to 
the home. We included all residents in the intervention 
activities except those who had diﬃ  culty sitting, or were 
breathless at rest. We recruited additional participants for 
9 months after randomisation for an end of study cross-
sectional analysis, using the same criteria as described 
previously. Ethical review for the study was provided by 
the Joint University College London/University College 
London Hospital Commit tees on the Ethics of Human 
Research (Committee A).
Randomisation and masking
A statistician independent of the study randomised 
each home, immediately after baseline data collection in 
that home. We used a 1 to 1·5 randomisation to reduce 
intervention costs. Care homes were ﬁ rst stratiﬁ ed by 
location and then minimised into intervention and 
control groups by type of home provider (local authority, 
voluntary, private and care home, private and nursing 
home) and size of home (<32 or ≥32 residents). 
Researchers collecting follow-up data from individual 
participants, and the participants themselves, were 
inevitably aware of home randomisation because of the 
physiotherapists’ activities within the home. A researcher 
masked to study allocation coded NHS routine data; 
however, because of the unbalanced randomisation we 
were not able to mask the researchers doing the ﬁ nal 
statistical analyses to assignments.
Procedures
For the control home, we delivered one session of 
training in depression awareness to staﬀ , ensuring that 
they were aware of present best care for the identiﬁ cation 
and management of depression in this population, 
including encouraging discussion of depression, 
increasing activities (eg, playing games with group 
interaction), and referral to primary or secondary care 
when needed.
For the intervention group, we developed a package 
that included the depression awareness training, group 
exercise sessions, and a whole home component. 
Development of the active interventions was informed by 
physiotherapy and organisational change literature along 
with empirical data from two systematic re views.3,5,8 
Physiotherapists delivered all elements of the 
programme. Care-home staﬀ  were informed about 
individualised mobility assessments and exercise pre-
scriptions for each of the residents to encourage an 
increase in residents’ physical activity. We delivered 
exercise in groups to enhance adherence, increase social 
323 available care homes
143 not approached
16 too large
35 too small
57 more than 50% dementia beds
3 pilot homes
32 Primary Care Trust approval not received
180 eligible homes approached
82 declined to take part
25 did not want to take part
53 did not respond
4 closed
98 homes assessed for study entry
20 homes not recruited
3 too few residents
2 home too busy
4 residents too frail or disabled
7 residents too cognitively impaired
1 not enough older than 65 years
3 not required
78 homes included and randomised
Figure 1: Recruitment of care homes
All care homes* Study care homes
Total Intervention Control
Number 323 78 35 43
Type† 
Nursing 81 (25%) 18 (23%) 9 (26%) 9 (21%)
Residential 242 (75%) 60 (77%) 26 (74%) 34 (79%)
Ownership
Private 262 (81%) 61 (78%) 28 (80%) 33 (77%)
Voluntary or charity 36 (11%) 16 (21%) 7 (20%) 9 (21%)
Local authority 25 (8%) 1 (1%) 0 1 (2%)
Size 
<32 beds 158 43 20 23
≥32 beds 165 35 15 20
Mean number of beds (SD) 34·89 (19·62) 31·41 (11·49) 31·54 (12·15) 31·30 (11·08)
Median cohort participants per 
home (IQR)
·· 11 (8–15) 11 (7–15) 11 (9–15)
Data are n or n (%) unless otherwise speciﬁ ed. *All care homes registered on the Care Quality Commission website 
within the two geographical regions of the trial (northeast London, and Coventry and Warwickshire) during 
development of the trial (in 2008). †Minimisation factors were type of home (local authority, voluntary, private and 
care home, private and nursing home) and size of home (32 beds or fewer, or more than 32 beds).
Table 1: Cluster (care home) characteristics 
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interaction, and reduce the cost per resident.9,10 The 
exercise classes were designed to provide a moderate 
intensity strength and aerobic training stimulus.8 The 
twice-weekly physiotherapist-led 45 min sessions ran for 
up to 12 months (intended length 12 months, no 
minimum duration) in each home and provided a 
moderately intense exercise stimulus via progressive 
aerobic and resistance training activities to be done while 
sitting and standing, using simple, accessible exercise 
equipment supported by music tracks selected for their 
facilitatory eﬀ ects.11 As part of the whole home approach 
the physiotherapists also engaged the care-home staﬀ 
and managers in encouraging residents to be more 
physically active in their daily lives.
Our primary outcome was the geriatric depression 
scale-15 (GDS-15), which was developed and validated 
for measurement of depressive symptoms among 
2078 eligible residents (in 78 homes)
1171 excluded
524 home decision
278 too ill
245 not appropriate 
to take part
329 next of kin decision
164 next of kin refused
136 next of kin did 
not respond
29 no next of kin
318 resident decision
318 refused
907 with consent or agreement
before randomisation
16 excluded
6 died
10 no usable data until 
after randomisation
891 with usable data at randomisation
493 in 43 control homes
493 provided usable data
420 completed GDS-15
200 in depressed cohort
398 in 35 intervention homes
398 provided usable data
345 completed GDS-15
174 in depressed cohort
64 died
429 alive at 6 month 
follow-up (43 homes)
413 provided usable data
308 completed GDS-15
174 of depressed cohort alive
136 completed GDS-15
50 died
348 alive at 6 month 
follow-up (35 homes)
338 provided usable data
263 completed GDS-15
152 of depressed cohort alive
123 completed GDS-1
50 died
379 alive at 12 month 
follow-up (43 homes)
347 provided usable data
263 completed GDS-15
48 died
300 alive at 12 month 
follow-up (35 homes)
285 provided usable data
230 completed GDS-15
Figure 2: Recruitment and follow-up of cohort participants
GDS-15=geriatric depression scale 15.
Intervention Control 
N n (%) Mean (SD) N n (%) Mean (SD) 
Demographic data
Women 398 294 (74%) ·· 493 383 (78%) ··
White 393 385 (98%) ·· 488 480 (98%) ··
Taking antidepressants 397 110 (28%) ·· 490 156 (32%) ··
Age at baseline (years) 396 ·· 86·7 (7·2) 490 ·· 86·3 (7·5)
Age when left full-time 
education (years)
304 ·· 15·0 (1·8) 348 ·· 14·9 (1·9)
Years in home 392 ·· 2·4 (2·6) 488 ·· 2·5 (2·6)
Assessment data
Depressed (GDS-15 ≥5 or 
equivalent)*
345 174 (50%) ·· 420 200 (48%) ··
GDS-15 score (0–15, 0=best) 345 ·· 4·8 (3·3) 420 ·· 4·8 (3·3)
MMSE score (0–30, 30=best) 346 ·· 18·7 (6·9) 404 ·· 18·1 (6·6)
SPPB score (0–12, 12=best) 348 ·· 1·9 (2·2) 413 ·· 1·8 (2·0
EQ-5D score (–0·594 to 1, 
1=best)
297 ·· 0·54 (0·39) 335 ·· 0·59 (0·37)
Pain today 
None 335 221 (66%) ·· 397 264 (66%) ··
Mild-moderate 335 107 (32%) ·· 397 116 (29%) ··
Severe 335 7 (2%) ·· 397 17 (4%) ··
Fear of falling 341 141 (41%) ·· 405 189 (47%) ··
Proxy data
Social engagement 
High 342 211 (62%) ·· 435 259 (60%) ··
Medium 342 97 (28%) ·· 435 133 (31%) ··
Low 342 34 (10%) ·· 435 43 (10%) ··
Barthel index (0–100, 
100=best)
337 ·· 54·5 (29·4) 417 ·· 54·0 (27·8)
Proxy EQ-5D (–0·594 to 1, 
1=best)
345 ·· 0·44 (0·35) 431 ·· 0·46 (0·34)
Comorbidities recorded in care-home records
Cancer 389 28 (7%) ·· 485 40 (8%) ··
Stroke 392 97 (25%) ·· 488 109 (22%) ··
Dementia 393 113 (29%) ·· 488 134 (27%) ··
Depression 392 84 (21%) ·· 486 96 (20%) ··
Anxiety 391 67 (17%) ·· 485 84 (17%) ··
Osteoporosis 392 45 (11%) ·· 486 50 (10%) ··
Chronic lung disease 391 47 (12%) ·· 489 56 (11%) ··
Urinary incontinence 393 214 (54%) ·· 489 286 (58%) ··
GDS-15=geriatric depression scale 15. MMSE=mini-mental state examination. SPPB=short physical performance 
battery. EQ-5D=European quality of life-5 dimensions. *When fewer than 15 items on the GDS were completed, we 
deemed depression to be ﬁ ve positive responses when 13 or more items were completed, four positive responses when 
11 or 12 items were completed, and three positive responses when 10 items were completed; nine or fewer items 
completed was deemed missing data. 
Table 2: Baseline characteristics of all cohort participants (N=891)
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elderly people.12 We deﬁ ned depression as having ﬁ ve or 
more depressive symptoms on GDS-15 or equivalent for 
those with 10–14 responses (ﬁ ve positive responses 
when 13 or more items completed, four positive 
responses when 11 or 12 items completed, and three 
positive responses when 10 items completed; nine or 
fewer items completed was deemed missing data). This 
approach seems to give the best sensitivity and 
speciﬁ city for presence or absence of depressive mood.13 
Our three coprimary analyses were: cohort analysis—
number of depressive symptoms 12 months after 
randomisation in those recruited before randomisation; 
depressed cohort ana lysis—number of depressive 
symptoms 6 months after randomisation in those 
recruited before randomisation and depressed at 
baseline; and cross-sectional analysis—prevalence of 
depression among all participants resident in a study 
home at 12 months.
Our cohort analyses included only study participants 
present at randomisation. We report these analyses for 
all participants, and separately for those with depression, 
because we were testing a whole home intervention 
whose eﬀ ects—positive or negative—could aﬀ ect all 
residents, not only those with depression at baseline. We 
included residents recruited after care homes were 
randomised for our end-of-study cross-sectional analyses 
to ensure that we could estimate the long-term eﬀ ects of 
our intervention on the prevalence of depression in 
participating care homes rather than only its eﬀ ect on 
relatively healthy cohort survivors.
Study researchers measured cognitive function using 
the mini-mental state examination (MMSE14), quality of 
life using the European quality of life-5 dimensions 
instrument (EQ-5D15), and fear of falling using a yes or 
no question, present level of pain on a ﬁ ve point ordinal 
scale conditional on the EQ-5D pain question, and used 
the short physical performance battery (SPPB) to 
measure functional performance (assessment data).16 
The resident’s main carer, or home manager, completed 
a proxy EQ-5D, Barthel index, and social engagement 
scale (proxy data).15–18 Researchers also collected data for 
comorbidities, length of residence, present medication, 
and demographic data from care-home records (care-
home data). We collected data for peripheral fractures 
and deaths from care-home and NHS records. We 
deﬁ ned an adverse event occurring during the exercise 
groups or study assessments as one that required ex-
ternal medical attention as a consequence of participation 
in the study.
Cohort participants completed the same questionnaire 
instruments at baseline, and 6 and 12 months. We re-
peated the SPPB at 12 months. We collected care-home 
and proxy data (drug use over preceding week, proxy EQ-
5D, and social engagement scale) 3, 6, 9, and 12 months 
after the home was randomised.
Statistical analysis
To show an increase in the rate of remission of depression 
after 6 months from 25% to 40% in the depressed cohort, 
with 80% power at the 5% signiﬁ cance level, using a 1 to 
1·5 randomisation, requires data for 343 participants. 
Assuming 32 residents per home, a 50% recruitment 
rate, 40% prevalence of depression, and 15% loss to 
follow-up at 6 months the average cluster size would be 
5·44. We inﬂ ated the sample size by 1·22 to allow for an 
intracluster correlation (ICC) co eﬃ  cient of 0·05. We 
aimed to recruit 1232 (≈[343 × 1·22] / [0·4 × 0·85]) partici-
pants from 77 homes.
Examination of baseline data after randomisation of 
47 homes showed that maintenance of our original 
recruitment target gave insuﬃ  cient power for the 
outcome of remission from depression at 6 months. 
With the agreement of the trial steering committee, data 
monitoring ethics committee, and funder, we replaced 
this outcome with mean diﬀ erence in number of 
depressive symptoms on the GDS-15 at 6 months as our 
primary outcome for the depressed cohort. We set the 
clinically important diﬀ erence in the GDS-15 as 
1·2 points on the basis of established data.19 Keeping our 
original recruitment target (77 homes) provided ample 
statistical power for all three coprimary analyses.
For cohort analyses we included residents in the home 
from which they were recruited. For cross-sectional 
analyses we included residents in the home in which they 
were resident at the end of the study. To avoid obtaining 
biased estimates in the presence of missing data, we used 
mixed models to account for clustering, instead of the 
generalised estimating equations speciﬁ ed in the 
published protocol.7,20 All analyses were done with Stata 
(version 11), using the xtmixed command to ﬁ t linear 
mixed models for continuous outcomes and the xtmelogit 
command to ﬁ t logistic mixed models for binary outcomes, 
with the exception of ordinal and count outcomes, for 
which SAS (version 9.2) proc glimmix was used. All 
models included the prespeciﬁ ed covariates of: location, 
type of home provider, size of home, proportion of 
residents with moderate to severe cognitive impair ment 
in the home at baseline (except when the MMSE was the 
outcome), sex, age at time of analysis, on anti depressants 
Intervention Control 
N n (%) Mean (SD) N n (%) Mean (SD)
Women 355 266 (75%) ·· 396 313 (79%) ··
White 353 344 (97%) ·· 392 384 (98%) ··
Age at time of recruitment 
(years)
355 ·· 86·5 (7·6) 394 ·· 86·0 (7·7)
Age when left full-time 
education (years)
283 ·· 14·9 (1·8) 284 ·· 15·0 (1·8)
Years in home 302 ·· 2·5 (2·8) 353 ·· 2·4 (2·7)
*751 of 775 residents provided usable outcome data; for this comparison, intervention and control deﬁ ned by the 
homes residents were in at 12 month follow-up. 
Table 3: Baseline characteristics of all cross-sectional participants (N=751)*
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at baseline, SPPB at baseline (except when proxy EQ-5D 
or social engagement was the outcome), mean baseline 
level of outcome (cohort analyses), or mean baseline level 
of outcome in the home (cross-sectional analysis), and 
included a random intercept for home. In a sensitivity 
analysis we did multilevel multiple imputation of the 
primary outcomes.21 For the purposes of measuring dose 
received we predeﬁ ned that attendance equivalent to one 
group per week would be classed as a minmum dose. This 
trial is registered with ISRCTN Register, number 
ISRCTN43769277.
Role of the funding source
A funder’s brief informed the development of this study. 
They had no role in the detailed design of the study; data 
analysis, data interpretation, or writing of the report; or 
the decision to submit the paper for publication. The 
corresponding author had full access to all the data in the 
study and had ﬁ nal responsibility for the decision to 
submit for publication.
Results 
Care homes were randomised between Dec 15, 2008, and 
April 9, 2010; follow-up was completed 1 year later. 
35 homes were assigned to intervention and 43 to control 
(1 to 1·2 ratio; ﬁ gure 1, table 1). The ﬁ nal allocation ratio 
of 1 to 1·2 was less than the 1 to 1·5 planned, but lies 
within bounds of chance.
We initially obtained consent or agreement to collect 
data from 907 (44%) of the 2078 eligible residents; for 
50 of 907 (6%) we could only collect proxy, care home, 
and NHS data. Before randomisation we obtained base-
line data from 891 participants (ﬁ gure 2; table 2). We 
obtained baseline assessment data from 781 of 891 (88%) 
residents; 765 of 781 (98%) of whom provided a GDS-15 
score. We obtained baseline proxy EQ-5D data for 776 of 
891 (87%) residents and drug data for 869 of 891 (98%). 
The sample were old (mean 86·5 years, range 65–107), 
predominantly (76%) women, with several comorbidities 
(tables 2, 3). Baseline characteristics were similar in 
inter vention and control groups (tables 2, 3).
In intervention homes, 80 of 365 (22%) of those in the 
cross-sectional analysis were recruited after random isation; 
in control homes this proportion was 52 of 410 (13%; 
table 3). The baseline characteristics of par ticipants 
recruited after randomisation were much the same as those 
of participants recruited before random isation and were 
much the same in both intervention and control groups 
(appendix pp 3, 5).
In the control homes 496 of 1126 (44%) staﬀ  attended 
depression awareness training. In the intervention homes 
at least 406 of 884 (46%) staﬀ  attended depression 
awareness and activity training (one training register 
is missing). One home did not receive the active 
intervention because residents were too disabled to 
participate. We delivered 3191 exercise sessions, open to 
both study participants and non-study participants, in 
34 homes; 90% of our target of 92 sets of sessions per 
home (some larger homes ran several sets of sessions). 
There were 31 705 individual attendances. On average 
9·9 residents attended each session; 5·3 (53%) of whom 
were trial participants. The median number of sessions 
Intervention Control Mean diﬀ erence 
(95% CI)
OR (95% CI) ICC
N 0 months 6 months 12 months N 0 months 6 months 12 months
GDS-15 score at 12 months 224 4·5 (3·2) ·· 4·6 (3·3) 260 4·7 (3·2) ·· 4·6 (3·3) 0·13* (–0·33 to 0·60) ·· 0·00
GDS-15 score at 6 months, in residents 
who were depressed at baseline
123 7·3 (2·2) 6·3 (3·1) ·· 136 7·4 (2·4) 6·5 (3·0) ·· 0·22† (–0·52 to 0·95) ·· 0·03
Prevalence of depression at 12 months 
in all participants with data
288 ·· 124 (43%) ·· 307 ·· 149 (49%) ·· ·· 0·76‡
(0·53 to 1·09)
0·00
Data are mean (SD) or n (%) unless otherwise speciﬁ ed. OR less than 1 or negative mean diﬀ erence favours intervention. OR=odds ratio. GDS-15=geriatric depression scale 15. ICC=model based intracluster 
correlation coeﬃ  cient. Each model adjusted for place (Coventry and Warwickshire or northeast London), type of home, size of home, proportion of residents with moderate to severe cognitive impairment at 
baseline, sex, on antidepressants at baseline, short physical performance battery at baseline, individual baseline GDS, and age at baseline (or mean of baseline GDS in the home and age at 12 months in 
prevalence analysis). *Two intervention and seven control residents excluded because of missing values in covariates. †One intervention and ﬁ ve control residents excluded because of missing values in 
covariates. ‡Seven intervention and 12 control residents excluded because of missing values in covariates.
Table 4: Eﬀ ect estimates from multivariable models for three coprimary GDS-15 outcomes
891 participants with usable data
present at randomisation
163 participants joining study 
after randomisation
643 participants in participating 
care home at end of study
285 in intervention home
358 in control home
132 participants in participating 
care home at end of study
80 in intervention home
52 in control home
775 eligible for cross-sectional analyses
365 residents in 35 intervention
homes at 12 months
355 provided usable data
288 completed GDS-15
410 residents in 43 control 
homes at 12 months
396 provided usable data
307 completed GDS-15
Figure 3: Recruitment and follow-up of cross-sectional participants
GDS-15=geriatric depression scale 15.
See Online for appendix
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attended by study participants in the intervention homes 
contributing to the 12 month overall cohort analysis was 
53 (IQR 15–69), 114 of 224 (51%) achieved the intended 
minimum dose of 51 attendances (one per working week) 
or more. Residents with depression at baseline were less 
likely than those without depression to achieve the 
minimum intended dose (40 of 99 [40%] vs 74 of 125 [59%]).
No care homes dropped out. In view of the poor state of 
health of our participants, we achieved very good follow-
up rates for the GDS-15; 493 of 679 (73%) in survivors in 
the cohort analysis at 12 months and 259 of 326 (79%) in 
survivors in the depressed cohort analysis at 6 months. 
We collected slightly more outcomes in intervention 
homes than control homes; of participants who were alive 
at 12 months we collected GDS-15 data for 230 of 
300 (77%) in intervention homes and 263 of 379 (69%) in 
control homes. The equivalent proportions for the proxy 
EQ-5D were 272 of 300 (91%) and 327 of 379 (86%). For 
the cross-sectional analysis we obtained GDS-15 score 
from 595 of 775 (77%) participants and care-home data for 
724 of 775 (93%) participants (ﬁ gure 3).
We identiﬁ ed no statistically signiﬁ cant, or clinically 
important, between-group diﬀ erences in the GDS-15 
score. In the overall cohort analysis, at 12 months, 
the adjusted mean diﬀ erence in GDS-15 scores was 
0·13 points (95% CI –0·33 to 0·60, p=0·5758; ie, 
control group slightly less depressed). The GDS-15 
scores at 12 months were much the same as baseline 
values in both groups (table 4). In the depressed-cohort 
analysis the adjusted mean diﬀ erence in GDS scores 
Baseline Follow-up Eﬀ ect (95% CI) ICC
Intervention Control Intervention Control
N n (%) Mean (SD) N n (%) Mean (SD) N n (%) Mean (SD) N n (%) Mean (SD) 
6 months
EQ-5D, self-
completed
214 ·· 0·58 (0·38) 201 ·· 0·60 (0·36) 214 ·· 0·59 (0·36) 201 ·· 0·57 (0·37) 0·03 (–0·02 to 0·08) 0·00
EQ-5D, 
proxy-
completed
278 ·· 0·44 (0·34) 336 ·· 0·47 (0·33) 278 ·· 0·45 (0·35) 336 ·· 0·44 (0·35) 0·05 (–0·01 to 0·11) 0·10
MMSE 257 ·· 19·5 (6·4) 269 ·· 19·1 (6·1) 257 ·· 18·8 (7·0) 269 ·· 17·8 (6·6) 0·53 (–0·16 to 1·22) 0·02
Fear of falling 246 95 (39%) ·· 281 132 (47%) ·· 281 93 (38%) ·· 281 136 (48%) ·· 0·76 (0·51 to 1·15) 0·00
Pain
None 245 169 (69%) ·· 278 184 (66%) ·· 245 168 (69%) ·· 278 196 (71%) ·· 1·08 (0·70 to 1·66)* 0·03*
Moderate 245 72 (29%) ·· 278 82 (30%) ·· 245 69 (28%) ·· 278 72 (26%) ·· ·· ··
Severe 245 4 (2%) ·· 278 12 (4%) ·· 245 8 (3%) ·· 278 10 (4%) ·· ·· ··
Social engagement
Low 276 27 (10%) ·· 341 35 (10%) ·· 276 43 (16%) ·· 341 47 (14%) ·· 1·11 (0·73 to 1·69)† 0·06†
Moderate 276 77 (28%) ·· 341 98 (29%) ·· 276 72 (26%) ·· 341 112 (33%) ·· ·· ··
High 276 172 (62%) ·· 341 208 (61%) ·· 276 161 (58%) ·· 341 182 (53%) ·· ·· ··
12 months
EQ-5D, self-
completed
184 ·· 0·56 (0·39) 182 ·· 0·60 (0·36) 184 ·· 0·56 (0·40) 182 ·· 0·58 (0·38) 0·01 (–0·05 to 0·06) 0·02
EQ-5D, 
proxy-
completed
232 ·· 0·46 (0·35) 294 ·· 0·49 (0·33) 232 ·· 0·43 (0·36) 294 ·· 0·45 (0·35) 0·01 (–0·06 to 0·08) 0·17
MMSE 227 ·· 19·6 (6·4) 234 ·· 19·0 (6·3) 227 ·· 18·2 (7·5) 234 ·· 17·3 (6·9) 0·02 (–0·78 to 0·83) 0·03
SPPB 231 ·· 2·2 (2·4) 261 ·· 2·0 (2·1) 231 ·· 1·9 (2·4) 261 ·· 1·6 (1·9) 0·30 (–0·05 to 0·64) 0·09
Fear of falling 211 84 (40%) ·· 228 115 (50%) ·· 211 76 (36%) ·· 228 95 (42%) ·· 1·07 (0·68 to 1·67) 0·00
Pain
None 216 143 (66%) ·· 227 153 (67%) ·· 216 155 (72%) ·· 227 167 (74%) ·· 1·07 (0·67 to 1·72)* 0·00*
Moderate 216 68 (31%) ·· 227 63 (28%) ·· 216 51 (24%) ·· 227 54 (24%) ·· ·· ··
Severe 216 5 (2%) ·· 227 11 (5%) ·· 216 10 (5%) ·· 227 6 (3%) ·· ·· ··
Social engagement
Low 235 22 (9%) ·· 306 28 (9%) ·· 235 27 (11%) ·· 306 46 (15%) ·· 1·08 (0·64 to 1·83)† 0·14†
Moderate 235 58 (25%) ·· 306 85 (28%) ·· 235 80 (34%) ·· 306 97 (32%) ·· ·· ··
High 235 155 (66%) ·· 306 193 (63%) ·· 235 128 (54%) ·· 306 163 (53%) ·· ·· ··
ICC=model based intracluster correlation coeﬃ  cient. EQ-5D=European quality of life-5 dimensions. MMSE=mini-mental state examination. SPPB=short physical performance battery. *For all pain. †For all 
social engagement.
Table 5: Secondary outcomes for all cohort participants (N=891)
Articles
www.thelancet.com   Vol 382   July 6, 2013 47
was 0·22 (95% CI –0·52 to 0·95, p=0·5662). The GDS-
15 scores decreased by a small amount—about one 
point—in both groups between baseline and 6 months 
(table 4). In the end of study cross-sectional analysis 
124 of 288 (43%) participants in the intervention group 
and 149 of 307 (49%) participants in the control group 
were depressed. The odds ratio for depression (inter-
vention: control) was 0·76 (95% CI 0·53–1·09, 
p=0·1304; table 4).
We identiﬁ ed no evidence of a diﬀ erence between 
intervention and control groups in any of our secondary 
comparisons, including for MMSE, fear of falling, and 
EQ-5D (tables 5, 6). Antidepressant use, mental health 
care team visits, and fracture and death rates did not 
diﬀ er between the intervention and control groups. No 
serious adverse events occurred during the exercise 
sessions or the assessments (appendix pp 3–5).
Discussion
Provision of group exercise classes over 12 months to 
residents of care homes older than 65 years had no eﬀ ect 
on depressive symptoms in this population, as measured 
by the GDS-15, irrespective of whether residents were 
depressed at baseline.
This is a large cluster randomised trial with robust 
ﬁ ndings. The results are clear and conclusively negative. 
Although uptake of the intervention was very good we 
recorded no evidence of any beneﬁ t on any of our primary 
or secondary outcome measures. The limits of the 
95% CIs for the possible beneﬁ t from the intervention 
for cohort and depressed cohort analyses exclude the 
likelihood of a clinically important eﬀ ect. Furthermore, 
in our cost–utility analysis the intervention was dom-
inated by the control, showing that this is not a cost-
eﬀ ective intervention (appendix p 7).
Participating homes were broadly representative of UK 
care homes, and participant baseline characteristics were 
much the same as population values.8,22,23 That nearly half 
of our participants were depressed, and that only a quarter 
of these cases were identiﬁ ed as depressed in care-home 
records underscores the relevance of depression as an 
important and neglected health problem needing 
treatment (appendix p 2).8 A quarter of residents were 
excluded by care-home man agers because their health was 
very poor, or because of concerns that approaching the 
resident might cause distress (ﬁ gure 2). Residents excluded 
because of very poor health would have been unlikely to be 
able to participate in the exercise groups and thus unlikely 
to beneﬁ t from the intervention.
Prevalence of depressive symptoms between baseline and 
follow-up did not diﬀ er in either group suggesting that both 
control and active interventions were in eﬀ ective. Also, the 
pattern of use of antidepressant drugs, or mental health 
team visits, did not diﬀ er, which might have masked a 
beneﬁ cial eﬀ ect from the inter vention (appendix p 3).
These ﬁ ndings eﬀ ectively exclude any possibility of a 
beneﬁ cial eﬀ ect on depressive symptoms, as measured 
on the GDS-15, from this exercise intervention. We have 
not excluded the possibility that our intervention might 
improve mobility; the limits of the 95% CI for the 
improvement in the SPPB in both the cohort analysis 
(–0·05 to 0·64) and the cross sectional analysis (–0·10 to 
0·58) include a minimum clinically important diﬀ erence 
of 0·5.24,25
We are aware of one other cluster randomised trial 
(N=191, follow-up 6 months) and one individually ran-
domised trial (N=134, follow-up 1 year) in care homes of 
exercise programmes that were much the same as ours 
with participants who had similar characteristics to 
ours.26,27 These studies also failed to show a beneﬁ t on 
Intervention Control Eﬀ ect (95% CI) ICC
N n (%) Mean (SD) N n (%) Mean (SD)
EQ-5D, self-completed 251 ·· 0·55 (0·39) 245 ·· 0·57 (0·38) 0·00 (–0·06 to 0·06) 0·00
EQ-5D, proxy-completed 346 ·· 0·45 (0·37) 378 ·· 0·44 (0·36) 0·02 (–0·05 to 0·08) 0·09
MMSE 284 ·· 18·6 (7·3) 285 ·· 17·0 (6·9) 0·68 (–0·46 to 1·82) 0·00
Fear of falling 273 103 (38%) ·· 280 110 (39%) ·· 1·16 (0·79 to 1·71) 0·00
SPPB 296 ·· 1·9 (2·4) 315 ·· 1·9 (1·5) 0·20 (–0·14 to 0·53)* 0·00*
Pain
None 278 198 (71%) ·· 281 213 (76%) ·· 1·39 (0·92 to 2·08) 0
Moderate 278 70 (25%) ·· 281 61 (22%) ·· ·· ··
Severe 278 10 (4%) ·· 281 7 (2%) ·· ·· ··
Social engagement
Low 349 49 (14%) ·· 386 51 (13%) ·· 0·89 (0·57 to 1·38)† 0·12†
Moderate 349 108 (31%) ·· 386 125 (32%) ·· ·· ··
High 349 192 (55%) ·· 386 210 (54%) ·· ·· ··
ICC=model based intracluster correlation coeﬃ  cient. EQ-5D=European quality of life-5 dimensions. MMSE=mini-mental state examination. SPPB=short physical performance 
battery. *For all pain. †For all social engagement. 
Table 6: Secondary outcomes for all cross-sectional participants (N=751)
Articles
48 www.thelancet.com   Vol 382   July 6, 2013
depressive symptoms (panel). We are aware of two other 
trials in care homes that excluded people with sub-
stantial cognitive impairment. One (N=389) showed no 
beneﬁ t on depressive symptoms from Tai Chi while the 
other (N=82) did ﬁ nd a beneﬁ t on depressive symptoms 
from qigong.28,29
The whole home nature of the active intervention 
meant that masking data collection within the homes 
after randomisation was not possible. Also support 
from care-home staﬀ  with data collection might diﬀ er 
between intervention and control homes. In inter-
vention homes we noted a consistent trend for the 
collection of more post-randomisation data. Our 
ﬁ ndings did not, however, change materially in a 
sensitivity analysis in which we imputed missing data 
or when an extreme scenario sensitivity analysis was 
done (data not shown).
The prevalence of depression in all residents at the 
end of the study is an important analysis to ensure the 
ﬁ ndings apply to all residents rather than only relatively 
healthy survivors. In this analysis we recruited more 
participants in the intervention homes than in the 
control homes after randomisation. Results were, how-
ever, unchanged by excluding the post randomisation 
participants. Since this is one of the largest trials done 
in a care-home setting and intra-cluster correlation co-
eﬃ  cients are mostly close to zero, we achieved precise 
estimates for our eﬀ ect sizes, suggesting that our con-
clusions are robust.
We designed an intervention package that had a good 
theoretical grounding designed to be delivered, over the 
long term, in a care-home environment. Participants 
had good exposure to the exercise sessions without any 
serious adverse events. The session design included 
ambulatory exercises, but because of the poor physical 
health and abilities of participants in the exercise 
group, the exercises were largely done while seated, 
reducing the intensity of the exercises. In a parallel 
process assessment we noted that our intervention had 
little eﬀ ect on physical activity within homes outside 
the times of exercise sessions8 and that although overall 
session attendance was good, many participants, par-
ticularly those with depression, attended too few 
sessions to gain the anticipated beneﬁ ts. Our approach, 
although popular with the homes, does not seem to 
have delivered an adequate dose to those with greatest 
need. Exercise interventions targeted at the ﬁ ttest, least 
cognitively impaired care-home residents with 
depression could be eﬀ ective.28–32
We have achieved very precise estimates of the 
possible eﬀ ect of the intervention. The study is, 
however, limited by the sensitivity of the measures 
used. Other, more sensitive, outcome measures might 
have shown a beneﬁ t, particularly for health-related 
quality of life. Nevertheless, this large study shows that 
group exercise is unlikely to be an eﬀ ective approach 
for prevention and treatment of depression among 
elderly residents of care homes. We cannot exclude the 
possibility that this intervention had beneﬁ cial eﬀ ects 
on other unmeasured outcomes such as cardiovascular 
ﬁ tness or staﬀ  morale within care homes.
Despite robust methodology, a strong theoretical 
grounding and good uptake of a moderately intensive 
exercise intervention, we identiﬁ ed no evidence that our 
intervention had a positive eﬀ ect on any of our carefully 
selected primary or secondary outcomes. This evidence 
does not support the use of this type of intervention to 
reduce the burden of depressive symptoms in residents 
of care homes, and alternative strategies for this 
common and important problem are needed.
Panel: Research in context
Systematic review
We have done three relevant systematic reviews to identify randomised controlled trials 
comparing the eﬀ ect of an exercise intervention on depressive symptoms with usual 
care or an attention control in elderly residents of care homes. First, we updated our 
review of the eﬀ ects of exercise on depression in elderly people.3 Search terms were: 
“exercise” OR “exercise therapy” OR “physical activity” OR “physical exercise” OR 
“dancing” OR “Tai Chi” OR Tai Ji OR “walking” OR “yoga” OR “physical ﬁ tness” OR 
“aerobic exercise” OR “exertion” AND “depression” OR “dysthymic disorder” OR 
“depressive disorder” OR “major depressive disorder” OR “depressive disorder major” 
OR “dysthymia” AND “elderly” OR “aged” OR “geriatric” OR “seniors” AND “randomised 
controlled trials”. Second, we updated our review of physical activity or the eﬀ ects of 
physical activity on elderly people with dementia.5 Search terms were: “exercise” OR 
“exercise therapy” OR “physical activity” OR “physical exercise” OR “dancing” OR 
“Tai Chi” OR Tai Ji OR “Walking” OR “yoga” OR “physical ﬁ tness” OR “aerobic exercise” 
OR “exertion” AND “elderly” OR “Aged” OR “geriatric” OR “seniors” AND “dementia” 
OR “Alzheimer disease” AND “randomised controlled trials”. Finally we updated our 
unpublished systematic review of cluster randomised controlled trials in residential and 
nursing homes. Search terms were “randomised trial” OR “clinical trial” AND “long term 
care facility” OR “long term care” OR “assisted living” OR “group homes” OR “homes of 
aged” OR “residential facilities” OR “nursing home” OR “retirement homes” OR 
“retirement communities” AND “cluster randomisation” OR “cluster randomisation” 
OR “cluster” OR “clustered” OR “clustering” OR “clusters” OR “group-randomised” OR 
“group-randomised” OR “randomisation unit” OR “randomisation unit”. Our searches 
were done in Scopus and PubMed, for papers reported between Jan 1, 2010, to Feb 13, 
2013. We indentiﬁ ed four relevant studies; Tsang and colleagues,28 Rolland and 
colleagues,27 Conradsson and colleagues,26 and Lam and colleagues.29 
Interpretation
The populations included the trials by Tsang and colleagues28 and Lam and colleagues29 
diﬀ er from our participants because they excluded residents with substantial cognitive 
impairment. Both the populations included, and the frequency and intensity of the 
exercise sessions, in the studies by Rolland and colleagues27 and Conradsson and 
colleagues26 are much the same as those in our trial. Neither, however, included a whole 
home component to the intervention.
Taken together with the earlier ﬁ ndings of Rolland and colleagues27 and Conradsson and 
colleagues,26 our ﬁ ndings show that regular moderately intense group exercise sessions 
do not live up to their promise as a treatment for depression in elderly residents of care 
homes. Nevertheless, exercise might be useful treatment for depression in ﬁ tter older 
people, including residents of care homes, who do not have substantial cognitive 
impairment and who are able to achieve more intense levels of sustained physical activity.
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